##common.search##
##search.searchResults##
-
EARLY PREDICTION OF PREECLAMPSIA IN PREGNANCIES AFTER IN VITRO FERTILIZATION USING BIOCHEMICAL AND DOPPLER MARKERS
Background. Pregnancies achieved by assisted reproductive technologies, particularly in vitro fertilization (IVF), are associated with an increased risk of hypertensive disorders, including preeclampsia. Early identification of women at high risk remains a major clinical challenge and is essential for improving maternal and perinatal outcomes.
Objective. To identify clinical, biochemical, and Doppler predictors of preeclampsia in women with IVF pregnancies and to develop an early risk prediction model.
Methods. A prospective cohort study was conducted at the Bukhara State Maternity Complex during 2023–2025. Eighty pregnant women after IVF were enrolled and divided into two groups: the main group included women who developed preeclampsia (n=48), and the control group included women with uncomplicated pregnancies (n=32). Clinical data, hemostasis parameters, serum levels of lactate dehydrogenase (LDH), homocysteine, C-reactive protein (CRP), vitamin D, and D-dimer were assessed. Doppler ultrasound of the uterine arteries was performed to evaluate pulsatility and resistance indices. Statistical analysis included correlation analysis, binary logistic regression, and calculation of odds ratios (OR) with 95% confidence intervals.
Results. Women who developed preeclampsia demonstrated significantly higher levels of LDH, homocysteine, CRP, and D-dimer, as well as lower vitamin D concentrations compared with controls (p<0.05). Doppler examination revealed increased uterine artery pulsatility and resistance indices, indicating impaired uteroplacental perfusion. Multivariate analysis identified elevated homocysteine, LDH, CRP, and vitamin D deficiency as independent predictors of preeclampsia after IVF. The proposed predictive model showed good diagnostic performance.
Conclusion. Combined assessment of biochemical markers and uterine artery Doppler indices enables early prediction of preeclampsia in IVF pregnancies and supports personalized preventive strategies.